Bill
Bill > S3610
NJ S3610
NJ S3610Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.
summary
Introduced
03/18/2019
03/18/2019
In Committee
03/18/2019
03/18/2019
Crossed Over
Passed
Dead
01/08/2020
01/08/2020
Introduced Session
2018-2019 Regular Session
Bill Summary
This bill requires a physician to offer to test a patient for dihydropyrimidine dehydrogenase deficiency prior to the patient undergoing chemotherapy. Dihydropyrimidine dehydrogenase deficiency is a disorder in which the human body experiences difficultly or is unable to breakdown chemotherapy drugs leading to a harmful reaction. Under the bill, health insurance plans in this State are to cover expenses incurred in conducting one test for dihydropyrimidine dehydrogenase deficiency every year.
AI Summary
This bill requires a physician to offer to test a patient for dihydropyrimidine dehydrogenase deficiency, a disorder in which the body has difficulty breaking down chemotherapy drugs, before the patient undergoes chemotherapy. The bill also requires health insurance plans in the state to cover the cost of one such test per year, as well as any necessary prescription drug treatment for the condition, if the plan provides prescription drug benefits. The bill directs the Commissioner of Health and the Department of Banking and Insurance to establish regulations to implement the provisions.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (on 03/18/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bills/BillView.asp?BillNumber=S3610 |
| BillText | https://www.njleg.state.nj.us/2018/Bills/S4000/3610_I1.HTM |
| Bill | https://www.njleg.state.nj.us/2018/Bills/S4000/3610_I1.PDF |
Loading...